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The requirement of divalent cations for binding of the 46 kDa mannose 6-phosphate receptors to phosphomannan and 
pentamannose 6-phosphate-substituted bovine serum albumin was examined. Receptors from human liver and human 
brain bound to both affinity ligands in the absence or presence of divalent cations with similar efficiency. The requirement 
for divalent cations therefore appears not to be necessary for the binding. 
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1. INTRODUCTION 
Two mannose 6-phosphate receptors (MPR) are 
known which differ in molecular mass, binding 
specificity and function. The larger of the two 
(MPR 215) has an apparent molecular mass of 
215 kDa (this receptor has recently been cloned 
and shown to be identical with the IGF II receptor; 
the cDNA predicts a size of about 275 kDa for the 
receptor polypeptide [15]) and binds mannose 
6-phosphate-containing ligands in the absence of 
divalent cations [l]. Binding of the ligands to the 
smaller receptor (MPR-46) with an apparent 
molecular mass of 46 kDa was reported to have an 
absolute requirement for divalent cations [2]. This 
property has led to the designation of the smaller 
receptor as cation-dependent MPR (MPRCD) and 
has been employed to separate MPR-46 and 
MPR-215 from lysates of Chinese hamster ovary 
cells [3]. 
We had previously noted that binding of a man- 
nose 6-phosphate-neoglycoprotein to MPR-46- 
bearing membranes of Morris hepatoma 7777 cells 
was largely independent of divalent cations [4]. 
Correspokdence address: K. von Figura, Universitat Gettingen, 
Biochemie II, Gosslerstr. 12d, D 3400 Giittingen, FRG. 
The lack of cation requirement for binding was at- 
tributed to the unusually large amount of mannose 
6-phosphate in the neoglycoprotein (130 mol per 
mol polypeptide) [5]. We were later unable to 
separate MPR-215 from MPR-46 on the basis of 
their differential requirement of cations for high- 
affinity binding. This prompted us to reinvestigate 
the effect of divalent cations on the binding of 
MPR-46 with annose 6-phosphate-containing 
ligands. 
2. MATERIALS AND METHODS 
2.1. Materials 
MPR-46 purified from human liver [6] was [‘*‘I]iodinated 
with the aid of iodogen (Pierce) according to Parker et al. [7] to 
a specific activity of 2500 cpm/ng receptor. Pentamannose 
6-phosphate-substituted bovine serum albumin (PMP-BSA) 
was kindly provided by Dr T. Braulke of this institute [S]. 
Phosphomannan-Sepharose 4B, Dictyostelium discoideum 
lysosomal enzyme-Sepharose 4B and rabbit antisera against 
human liver MPR-215 and MPR-46 were those previously 
described [6,8]. 
2.2. Binding of ‘251-MPR-46 to phosphomannan-Sepharose 4B 
“‘1-MPR-46 (40 000 cpm in 100~1 binding buffer: SO mM im- 
idazole1150 mM NaCl/S mM Na &glycerophosphate/O.OSVo 
Triton X-100/0.05% BSA) containing either 10 mM MgCl2 or 2 
mM EDTA was loaded on phosphomannan-Sepharose 4B col- 
umns (500~1 bed volume) at 4°C and incubated for 5 min. Each 
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column was washed under its loading conditions with 8 ml 
binding buffer followed by 5 ml binding buffer/2 mM EDTA. 
The receptor was eluted with 6 ml of 0.5 mM mannose 
6-phosphate in binding buffer. The fraction was assayed for 
radioactivity, pooled as indicated in fig.1, dialyzed against 10 
mM NH4 acetate, pH 7.0/0.05% Triton X-100 and lyophilized. 
Samples were dissolved in Hz0 and precipitated with 80% 
acetone. One tenth of each sample was applied to SDS-PAGE 
[9]. The “‘1-MPR was visualized by autoradiography. 
2.3. Solid-phase binding assay 
Flexible microtiter wells were incubated for 6 h with 200 or 
500 ng PMP-BSA in 50~1 of 25 mM Tris-HCl, pH 7.0. The wells 
were washed 5 times with 50 mM Hepes/lSO mM NaCl/O. 1 Vo 
Tween 2010.1% Triton X-100/0.1% BSA and saturated over- 
night in the same buffer. I25 I-MPR-46 (20 000 cpm in 20 ~1 of 
50 mM Na phosphate, pH 7.0/150 mM NaCl/S mM Na fl- 
glycerophosphate/O. 1% Triton X-100/0.1 % BSA, supple- 
mented with EDTA, MgC12 and mannose 6-phosphate as in- 
dicated in table 1) was added. After 3 h incubation the wells 
were washed 5 times with the phosphate buffer/6 mM MgCl2, 
dried, cuf and counted. 
2.4. Purification of MPR-46 from human brain 
MPR-46 from human brain was purified in the presence and 
absence of divalent cations: typically IO g human brain (pooled 
material from cortex and white matter obtained after brain 
surgery) was homogenized in 20 ml of 50 mM imidazole, pH 
7.0/150 mM NaCI/S mM Na &glycerophosphate/O. 1 TIU/ml 
aprotinin/5 mM iodoacetamide/l mM EDTA/l mM phenylme- 
thylsulfonyl fluoride (buffer A) and centrifuged at 1000 x g. The 
pellet was resuspended in buffer A and spun again at 1000 x g. 
The 1000 x g supernatants were pooled and centrifuged for 1 h 
at 100000 x g. The pellet was extracted overnight in 30 ml buffer 
A substituted with 1% Triton X-100/0.1% Na deoxycholate. 
After centrifugation for 1 h at 100000 x g, the supernatant was 
applied to the D. discoideum lysosomal enzyme-Sepharose 4B 
column [6] either directly or after adjusting to 10 mM MnCl2. 
The flow-through (50 ml) was applied to the phosphomannan- 
Sepharose 4B column (15 ml bed volume). The 
phosphomannan-Sepharose 4B was washed with 3 I of either 
buffer A/5 mM EDTA or buffer A/IO mM MnCl2 prior to elu- 
tion with 120 ml buffer A/2 mM mannose 6-phosphate. The 
eluents were analyzed by Western blotting [lo] with a 1: 1 mix- 
ture of antisera against MPR-215 and MPR-46. 
3. RESULTS 
3.1. Binding of ‘251-MPR-46 to phosphomannan- 
Sepharose 4B 
MPR-46 purified to homogeneity from human 
liver was iodinated and assayed for binding to 
phosphomannan-Sepharose 4B in the presence of 
either 10 mM MgCl2 or 2 mM EDTA. More than 
70% of the receptor bound to the column under 
both conditions (fig.1). Receptor that was bound 
to the column in the presence of 10 mM MgC12 
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Fig.1. Binding of “‘1-MPR-46 to phosphomannan-Sepharose 
4B 12?-MPR-46 was loaded on the column in the presence of 
1OmM MgCl2 (0-0) or 2 mM EDTA (w). After 
washing under loading conditions the columns were eluted 
sequentially with 2 mM EDTA and 0.5 mM mannose 
6-phosphate (M6P) as indicated by arrows. Fractions of 1 ml 
were collected, assayed for radioactivity (bottom), pooled as 
indicated by horizontal bars and analyzed by SDS-PAGE 
followed by autoradiography (top). The position of MPR-46 is 
shown. A compression effect on MPR-46 by the high amounts 
of BSA in the sample can be noted. 
could not be eluted with 2 mM EDTA and required 
0.5 mM mannose 6-phosphate for release from the 
affinity matrix. This indicated that binding of 12’1- 
MPR-46 to phosphomannan-Sepharose 4B did not 
depend on divalent cations. 
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3.2. Binding of ‘2sI-MPR-46 to PMP-BSA 
To examine the binding of r2’I-MPR-46 to im- 
mobilized PMP-BSA, microtiter wells coated with 
PMP-BSA were incubated with 12?-MPR-46 in the 
presence of 6 mM MgC12 or 2 mM EDTA. Under 
both conditions, low but similar amounts of 12’1- 
MPR-46 bound to the solid phase (table 1). The 
binding was specific as indicated by the sensitivity 
to 5 mM mannose 6-phosphate. 
3.3. Isolation of MPR-46 from human brain by 
affinity chromatography in the absence of 
divalent cations 
The previous experiments had shown that 
binding of iodinated MPR-46 with mannose 
6-phosphate-containing ligands did not require 
divalent cations. To exclude the possibility that the 
lack of cation requirement was a result of secon- 
dary modifications of the receptor during storage 
or iodination, we investigated whether purification 
of MPR-46 on a phosphomannan-Sepharose 4B 
column could be achieved in the absence of 
divalent cations. 
A membrane extract from human brain was 
passed through a D. discoideum lysosomal en- 
zyme-Sepharose 4B column to remove MPR-215 
[2] and then over a phosphomannan-Sepharose 4B
column (an affinity matrix for both types of MPR, 
see [2]). After extensive washing the columns were 
eluted with 2 mM mannose 6-phosphate. The 
eluents were analyzed for the presence of the two 
receptors by Western blotting with a mixture of an- 
tisera against MPR-46 and MPR-215. In eluents of 
Table 1 
Binding of “‘I-MPR-46 to microtiter wells coated with 
PMP-BSA 
Addition Bound “‘1-MPR (cpm) 
A B 
2 mM EDTA 108fl 132~t8 
2 mM EDTA 
+ SmMM6P 22 
6 mM MgClz 92+4 135k23 
6 mM MgClz 
+5mMM6P 3 21 
Wells were coated with 200 (A) or 500 (B) ng PMP-BSA. The 
values for EDTA and MgC12 give the mean and range of 
duplicates. All values were corrected for background binding to 
wells coated with BSA alone (19 + 4 and 49 f 7 cpm in series A 
and B, respectively) 
Fig.2. Western blot of MPR-46 from human brain. Brain 
extracts were chromatographed sequentially on D. discoideum 
lysosomal enzyme-Sepharose 4B and phosphomannan- 
Sepharose 4B columns in the presence of MnClz (lane 2) or 
EDTA (lane 3). Aliquots of the mannose 6-phosphate luents 
from phosphomannan-Sepharose 4B corresponding to 0.2 g 
fresh tissue and 200 ng human liver MPR-46 (lane 1) were 
separated by SDS-PAGE, transferred to nitrocellulose and 
analyzed with a mixture of antisera against MPR-46 and 
MPR-215. The monomeric and dimeric forms of MPR-46 are 
marked (+). MPR-215 polypeptides (4) representing intact 
recepotor and an approx. 130 kDa fragment are present in lane 
3 due to their incomplete absorption by the preceding D. 
discoideum lysosomal enzyme-Sepharose 4B column. 
the D. discoideum lysosomal enzyme-Sepharose 4B 
column, only MPR-215 (and fragments thereof) 
was detectable (not shown). MPR-46 was detec- 
table only in the eluent from the phosphomannan- 
Sepharose 4B column (fig.2). Substitution of the 
binding and washing buffers with either 10 mM 
MnClJl mM EDTA or 1 mM EDTA yielded 
similar amounts of MPR-46 polypeptides. The 
monomeric forms of MPR-46 were accompanied 
by a small fraction of dimeric receptor forms, 
which was resistant against boiling in the presence 
of SDS and dithiothreitol. Dimeric forms were 
noted earlier in receptor preparations from bovine 
[2] and human [6] liver. In contrast to liver, several 
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distinct forms of monomeric and dimeric forms of 
MPR-46 were discernible in brain. The molecular 
basis for this heterogeneity is presently under in- 
vestigation. 
4. DISCUSSION 
Previous investigations had established an ab- 
solute requirement for divalent cations for high- 
affinity binding of MPR-46 [2,3,11,12]. Here, such 
a dependence was not detectable. The specificity of 
binding in the absence of divalent cations was suffi- 
cient to allow purification of the receptor from 
crude tissue extracts by affinity chromatography. 
Moreover, the yield in the absence or presence of 
divalent cations was comparable. 
Cation dependence was established for MPR-46 
from bovine liver [2]. It is possible that species 
variations account for the differences in cation re- 
quirement. However, the cation requirement may 
also depend on the type of affinity matrix. Cation 
dependence was observed for affinity matrices in 
which the phosphomannan was coupled directly to 
Sepharose 4B [2], while cation independence is 
observed with affinity matrices in which the phos- 
phomannan is coupled via a six-carbon-long spacer 
[6]. Our initial attempts to prepare affinity ma- 
trices for MPR-46 by coupling phosphomannan 
directly to Sepharose 4B, yielded gels with un- 
satisfactory binding capacities (Stein, M. un- 
published). It is therefore conceivable that high 
concentrations of divalent cations improve the in- 
teraction of MPR-46 with ligands if the accessibili- 
ty of the latter is unfavorable. 
The present observation of cation-independent 
binding of ligands to MPR-46 has precendents. 
Membranes of Morris hepatoma cells, which ex- 
press only MPR-46, retain 60% or more of their 
mannose 6-phosphate-binding sites in the presence 
of 10 mM EGTA [4]. Distler and Jourdian [13,14] 
purified a cation-independent MPR from bovine 
testes of apparent molecular mass 42 kDa. At low 
,&galactosidase concentrations binding of ,&galac- 
tosidase with the receptor was improved by high 
concentrations (20 mM) of MnC12. 
The present results and earlier observations in- 
dicate the need for caution in attempts to discrimi- 
nate between MPR-46 and MPR-215 solely on the 
basis of cation dependence. Furthermore, it ap- 
pears more appropriate to designate the smaller of 
the two receptors according to molecular mass 
(MPR-46) than according to its cation requirement 
(MPRCD). 
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